4//SEC Filing
Nabulsi Azmi 4
Accession 0001209191-24-002020
CIK 0001783183other
Filed
Jan 21, 7:00 PM ET
Accepted
Jan 22, 8:21 PM ET
Size
11.3 KB
Accession
0001209191-24-002020
Insider Transaction Report
Form 4
Nabulsi Azmi
Chief Operating Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-01-18+130,000→ 130,000 totalExercise: $7.60Exp: 2034-01-17→ Common Stock (130,000 underlying)
Footnotes (1)
- [F1]The stock option will vest with respect to 25% of the shares of common stock on January 18, 2025, and will vest with respect to the remaining shares in equal monthly installments over the following three years, subject to the reporting person's continuous service to the Company on the applicable vesting dates.
Issuer
Phathom Pharmaceuticals, Inc.
CIK 0001783183
Entity typeother
Related Parties
1- filerCIK 0001791412
Filing Metadata
- Form type
- 4
- Filed
- Jan 21, 7:00 PM ET
- Accepted
- Jan 22, 8:21 PM ET
- Size
- 11.3 KB